CLOV vs TLRY
Clover Health Investments Corp (CLOV) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported TLRY revenue for 2025-05-31 was $821.3M. Net income was -$2.18B. Revenue was up 4.1% from 2024-05-31 to 2025-05-31. TLRY currently screens at market cap $573.9M.
CLOV currently screens at market cap $1.55B. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the CLOV and TLRY stock pages for the full models.
Not investment advice.